A competitive inhibitor of human lysosomal beta-glucosidase, IC50 = 0.06 µM.1 Increases the activity of N370S mutant acid beta-glucosidase (GlcCerase) in Gaucher fibroblasts.2 Displays a direct pharmacological chaperone effect greatly increasing the amount of
* VAT and and shipping costs not included. Errors and price changes excepted